|
Nov 25, 2020
|
GBT Announces Participation in Upcoming Investor Conferences
|
|
|
Nov 13, 2020
|
GBT Announces Participation at the Stifel 2020 Virtual Healthcare Conference
|
|
|
Nov 09, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Nov 05, 2020
|
GBT Reports Recent Business Progress and Third Quarter 2020 Financial Results
|
|
|
Nov 04, 2020
|
GBT Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting & Exposition
|
|
|
Oct 29, 2020
|
GBT to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020
|
|
|
Oct 26, 2020
|
GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia
|
|
|
Oct 12, 2020
|
GBT Receives Rare Impact Award for Innovation from the National Organization for Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets.
|
|
|
Oct 05, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Sep 09, 2020
|
GBT and Sickle Cell Disease Association of America to Host 9th Annual Sickle Cell Disease (SCD) Therapeutics Conference
|
|
|
Sep 08, 2020
|
GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta® (voxelotor) in Six Middle Eastern Countries
|
|
|
Sep 04, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Sep 03, 2020
|
GBT Announces Participation in Upcoming Investor Conferences
|
|
|
Aug 07, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Aug 05, 2020
|
GBT Reports Recent Business Progress and Second Quarter 2020 Financial Results
|
|
|
Jul 30, 2020
|
GBT Announces Participation in Upcoming Investor Conferences
|
|
|
Jul 29, 2020
|
GBT to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
|
|
|
Jul 08, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Jun 25, 2020
|
GBT Awards $250,000 in ACCEL Grants to Advance Access to Care for People Living with Sickle Cell Disease
|
|
|
Jun 24, 2020
|
GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (voxelotor) to Treat Sickle Cell Patients in Europe
|
|
|
Jun 08, 2020
|
GBT Announces Plans to Seek Expanded Labeling for Oxbryta® (voxelotor) to Treat Children Ages 4 to 11 Years with Sickle Cell Disease
|
|
|
Jun 03, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Jun 02, 2020
|
GBT Announces Participation at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast
|
|
|
May 14, 2020
|
GBT Announces Upcoming Data Presentations During Virtual Edition of 25th Annual European Hematology Association Congress
|
|
|
May 07, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
May 06, 2020
|
GBT Reports Recent Business Progress and First Quarter 2020 Financial Results
|
|
|
Apr 29, 2020
|
GBT to Announce First Quarter 2020 Financial Results on Wednesday, May 6, 2020
|
|
|
Apr 03, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Apr 02, 2020
|
GBT Commits $250,000 to Support the Sickle Cell Disease Community During COVID-19 Pandemic
|
|
|
Mar 17, 2020
|
GBT Takes Steps to Support Public Health Efforts to Address COVID-19 Pandemic
|
|
|
Mar 04, 2020
|
GBT Announces New Employment Inducement Grants
|
|
|
Feb 26, 2020
|
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2019 Financial Results
|
|
|
Feb 25, 2020
|
GBT Announces Participation at the Cowen and Company 40th Annual Healthcare Conference
|
|
|
Feb 20, 2020
|
GBT Accepting Proposals for 2020 ACCEL Grants to Support Novel Access-to-Care Programs for People Living with Sickle Cell Disease
|
|
|
Feb 19, 2020
|
GBT to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020
|
|